Nova Leap Health Corp
(NLH.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 584 | 885 | 1,356 | 861 | 544 |
| Income taxes - deferred | 321 | 303 | 487 | -1,222 | -1,196 |
| Accounts receivable | -46 | 101 | 417 | -763 | 273 |
| Accounts payable and accrued liabilities | 323 | -1 | -67 | 363 | 4 |
| Other Working Capital | 242 | 100 | -110 | -596 | 648 |
| Other Operating Activity | -36 | 767 | -1,062 | 3,536 | 2,739 |
| Operating Cash Flow | $1,388 | $2,155 | $1,021 | $2,180 | $3,012 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -28 | -71 | N/A | -7 |
| Net Acquisitions | -1,566 | N/A | 0 | -7,402 | -1,613 |
| Other Investing Activity | 0 | 5 | 15 | 0 | 56 |
| Investing Cash Flow | $-1,591 | $-23 | $-56 | $-7,402 | $-1,563 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,143 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 0 | 1,600 | 681 |
| Debt Repayment | -484 | -2,460 | -2,936 | -1,447 | -1,580 |
| Common Stock Issued | N/A | 0 | 1,788 | 4,380 | N/A |
| Other Financing Activity | 70 | -56 | -266 | -203 | 574 |
| Financing Cash Flow | $730 | $-2,516 | $-1,414 | $4,330 | $-325 |
| Exchange Rate Effect | -19 | 7 | -12 | -154 | 20 |
| Beginning Cash Position | 895 | 1,273 | 1,733 | 2,779 | 1,635 |
| End Cash Position | 1,403 | 895 | 1,273 | 1,733 | 2,779 |
| Net Cash Flow | $527 | $-385 | $-449 | $-891 | $1,124 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,388 | 2,155 | 1,021 | 2,180 | 3,012 |
| Capital Expenditure | -25 | -28 | -71 | N/A | -7 |
| Free Cash Flow | 1,363 | 2,127 | 949 | 2,180 | 3,006 |